|Bid||83.13 x 800|
|Ask||83.33 x 900|
|Day's Range||82.62 - 83.34|
|52 Week Range||77.04 - 98.52|
|Beta (5Y Monthly)||0.55|
|PE Ratio (TTM)||21.11|
|Forward Dividend & Yield||3.20 (3.84%)|
|Ex-Dividend Date||Mar. 04, 2021|
|1y Target Est||104.80|
These stocks are all trading near their 52-week lows, but they're all solid investments to hold over the long term.
Investors aren't impressed with the early-stage results from the biotech's lead cancer therapy candidate.
bluebird (BLUE) provides information on stock distribution ratio and cash allocation for the planned spin-off of the oncology business.